Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy.

导出 OA

翻译打印收藏纠错

作者： Jonatan,Kaszubski ^[1] ; Maciej,Gagat ^[2] ; Alina,Grzanka ^[3] ; Agata,Wawrzyniak ^[4] ; Wiesława,Niklińska ^[5] ; Magdalena,Łapot ^[6] ; Agnieszka,Żuryń ^[3]

作者单位： Vascular Biology Student Research Club, Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland. ^[1] Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.;Faculty of Medicine, Collegium Medicum, Mazovian Academy in Płock, 09-402 Płock, Poland. ^[2] Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland. ^[3] Department of Histology and Embryology, Institute of Medical Sciences, College of Medical Sciences of the University of Rzeszow, University of Rzeszów, 35-310 Rzeszów, Poland. ^[4] Department of Histology and Embryology, Medical University of Bialystok, 15-269 Białystok, Poland. ^[5] Faculty of Medicine, Collegium Medicum, Mazovian Academy in Płock, 09-402 Płock, Poland. ^[6]

关键词 CDK inhibitors (CDKIs)CDK2 CDK4/6 CDK7/9 acral melanoma cyclin-dependent kinases (CDKs)melanoma mucosal melanoma rare subtypes of melanoma uveal melanoma